Annual Cash & Cash Equivalents:
$794.06M+$216.31M(+37.44%)Summary
- As of today, DLB annual cash & cash equivalents is $794.06 million, with the most recent change of +$216.31 million (+37.44%) on September 26, 2025.
- During the last 3 years, DLB annual cash & cash equivalents has fallen by -$23.52 million (-2.88%).
- DLB annual cash & cash equivalents is now -37.57% below its all-time high of $1.27 billion, reached on September 24, 2021.
Performance
DLB Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$794.06M+$36.74M(+4.85%)Summary
- As of today, DLB quarterly cash & cash equivalents is $794.06 million, with the most recent change of +$36.74 million (+4.85%) on September 1, 2025.
- Over the past year, DLB quarterly cash & cash equivalents has increased by +$216.31 million (+37.44%).
- DLB quarterly cash & cash equivalents is now -37.75% below its all-time high of $1.28 billion, reached on June 25, 2021.
Performance
DLB Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DLB Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +37.4% | +37.4% |
| 3Y3 Years | -2.9% | -2.9% |
| 5Y5 Years | -29.5% | -29.5% |
DLB Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -17.0% | +37.4% | -17.0% | +37.4% |
| 5Y | 5-Year | -37.6% | +37.4% | -37.8% | +37.4% |
| All-Time | All-Time | -37.6% | +3413.3% | -37.8% | +1182.4% |
DLB Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | $794.06M(+37.4%) | - |
| Sep 2025 | - | $794.06M(+4.9%) |
| Jun 2025 | - | $757.33M(+0.9%) |
| Mar 2025 | - | $750.34M(+22.7%) |
| Dec 2024 | - | $611.66M(+5.9%) |
| Sep 2024 | $577.75M(-39.6%) | $577.75M(-36.2%) |
| Jun 2024 | - | $905.95M(-3.6%) |
| Mar 2024 | - | $940.22M(+10.7%) |
| Dec 2023 | - | $849.48M(-11.2%) |
| Sep 2023 | $957.11M(+17.1%) | - |
| Sep 2023 | - | $957.11M(+3.7%) |
| Jun 2023 | - | $923.37M(+12.6%) |
| Mar 2023 | - | $819.81M(+7.3%) |
| Dec 2022 | - | $764.35M(-6.5%) |
| Sep 2022 | $817.58M(-35.7%) | $817.58M(-20.2%) |
| Jun 2022 | - | $1.02B(-2.5%) |
| Mar 2022 | - | $1.05B(-8.3%) |
| Dec 2021 | - | $1.15B(-10.0%) |
| Sep 2021 | $1.27B(+12.9%) | $1.27B(-0.3%) |
| Jun 2021 | - | $1.28B(+8.8%) |
| Mar 2021 | - | $1.17B(+0.0%) |
| Dec 2020 | - | $1.17B(+4.0%) |
| Sep 2020 | $1.13B(+21.9%) | $1.13B(+7.0%) |
| Jun 2020 | - | $1.05B(+15.8%) |
| Mar 2020 | - | $909.30M(-1.5%) |
| Dec 2019 | - | $923.39M(-0.1%) |
| Sep 2019 | $924.74M(-16.2%) | $924.74M(+9.5%) |
| Jun 2019 | - | $844.78M(-5.5%) |
| Mar 2019 | - | $893.54M(-8.4%) |
| Dec 2018 | - | $975.34M(-11.6%) |
| Sep 2018 | $1.10B(+25.1%) | $1.10B(+6.8%) |
| Jun 2018 | - | $1.03B(+8.2%) |
| Mar 2018 | - | $954.10M(+11.4%) |
| Dec 2017 | - | $856.63M(-2.9%) |
| Sep 2017 | $882.13M(+37.5%) | $882.13M(+4.2%) |
| Jun 2017 | - | $846.47M(+15.4%) |
| Mar 2017 | - | $733.26M(+7.4%) |
| Dec 2016 | - | $682.73M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | $641.39M(-4.8%) | $641.39M(-11.5%) |
| Jun 2016 | - | $724.44M(+14.9%) |
| Mar 2016 | - | $630.75M(+3.3%) |
| Dec 2015 | - | $610.57M(-9.4%) |
| Sep 2015 | $673.76M(-16.0%) | $673.76M(+5.5%) |
| Jun 2015 | - | $638.62M(-9.3%) |
| Mar 2015 | - | $704.31M(+13.1%) |
| Dec 2014 | - | $622.60M(-22.4%) |
| Sep 2014 | $801.82M(+34.8%) | $801.82M(+3.5%) |
| Jun 2014 | - | $774.88M(+4.5%) |
| Mar 2014 | - | $741.33M(+11.1%) |
| Dec 2013 | - | $667.39M(+12.2%) |
| Sep 2013 | $594.66M(-25.2%) | $594.66M(+14.8%) |
| Jun 2013 | - | $517.90M(+14.3%) |
| Mar 2013 | - | $452.92M(+4.2%) |
| Dec 2012 | - | $434.87M(-45.3%) |
| Sep 2012 | $795.29M(+8.1%) | $795.29M(-19.9%) |
| Jun 2012 | - | $992.81M(-9.6%) |
| Mar 2012 | - | $1.10B(+7.5%) |
| Dec 2011 | - | $1.02B(+38.9%) |
| Sep 2009 | $735.49M(+97.4%) | $735.49M(+28.0%) |
| Jun 2009 | - | $574.65M(+1.5%) |
| Mar 2009 | - | $566.07M(+35.0%) |
| Jun 2008 | - | $419.46M(+11.4%) |
| Mar 2008 | - | $376.41M(-21.7%) |
| Dec 2007 | - | $480.97M(-10.3%) |
| Jun 2007 | - | $536.46M(+0.8%) |
| Mar 2007 | - | $532.39M(+0.8%) |
| Dec 2006 | - | $528.39M(+18.0%) |
| Jun 2006 | - | $447.81M(-0.7%) |
| Mar 2006 | - | $450.83M(+11.4%) |
| Dec 2005 | - | $404.69M(+8.6%) |
| Sep 2005 | $372.61M(+40.1%) | $372.61M(+3.0%) |
| Jun 2005 | - | $361.73M(+284.5%) |
| Dec 2004 | - | $94.09M(-64.6%) |
| Sep 2004 | $265.88M(+329.4%) | $265.88M(+329.4%) |
| Sep 2003 | $61.92M(+65.6%) | $61.92M |
| Sep 2002 | $37.39M(+65.4%) | - |
| Sep 2001 | $22.60M | - |
FAQ
- What is Dolby Laboratories, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Dolby Laboratories, Inc.?
- What is Dolby Laboratories, Inc. annual cash & cash equivalents year-on-year change?
- What is Dolby Laboratories, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Dolby Laboratories, Inc.?
- What is Dolby Laboratories, Inc. quarterly cash & cash equivalents year-on-year change?
What is Dolby Laboratories, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of DLB is $794.06M
What is the all-time high annual cash & cash equivalents for Dolby Laboratories, Inc.?
Dolby Laboratories, Inc. all-time high annual cash & cash equivalents is $1.27B
What is Dolby Laboratories, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, DLB annual cash & cash equivalents has changed by +$216.31M (+37.44%)
What is Dolby Laboratories, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DLB is $794.06M
What is the all-time high quarterly cash & cash equivalents for Dolby Laboratories, Inc.?
Dolby Laboratories, Inc. all-time high quarterly cash & cash equivalents is $1.28B
What is Dolby Laboratories, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, DLB quarterly cash & cash equivalents has changed by +$216.31M (+37.44%)